HIK.L - Hikma Pharmaceuticals PLC
| Previous close | 1,801.50 |
| Open | 1,802.50 |
| Bid | 1,816.00 x 0 |
| Ask | 1,817.00 x 0 |
| Day's range | 1,802.13 - 1,832.50 |
| 52-week range | 1,174.50 - 1,915.50 |
| Volume | |
| Avg. volume | 549,305 |
| Market cap | 4.01B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 27.12 |
| EPS (TTM) | 0.67 |
| Earnings date | 03 Aug 2023 |
| Forward dividend & yield | 0.46 (2.52%) |
| Ex-dividend date | 23 Mar 2023 |
| 1y target est | 20.95 |
Yahoo Finance UKFTSE 100: Ocado at risk, IMI in – how London Stock Exchange is set to reshuffle the index
The latest reshuffle of the premier index will be announced after the close of play this Wednesday.
Simply Wall St.Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst institutional investors who own 52%
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
- Reuters
Hikma Pharma names Mishlawi as next CEO
The London-based company said once Mishlawi takes up the role, Said Darwazah will step down as acting CEO and return to his role as executive chairman. Mishlawi, who has been with Hikma for more than 26 years over two separate stints, was instrumental in the growth and global expansion of the group's injectables business into a market-leading position.
- Simply Wall St.
Those who invested in Hikma Pharmaceuticals (LON:HIK) five years ago are up 57%
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...
- Simply Wall St.
Hikma Pharmaceuticals Full Year 2022 Earnings: EPS Misses Expectations
Hikma Pharmaceuticals ( LON:HIK ) Full Year 2022 Results Key Financial Results Revenue: US$2.52b (down 1.4% from FY...
- Simply Wall St.
Is Hikma Pharmaceuticals PLC's (LON:HIK) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Hikma Pharmaceuticals (LON:HIK) has had a great run on the share market with its stock up by a significant 15% over the...
ReutersHikma accuses Amarin of suppressing generic versions of heart pill
Generic drugmaker Hikma Pharmaceuticals USA Inc has sued Amarin Pharma Inc, accusing it of using illegal tactics to delay generic competition for its heart drug Vascepa. In a complaint filed Tuesday in Trenton, New Jersey federal court, Hikma claimed that Amarin "deliberately and meticulously locked up the supply" of the key ingredient needed to make generic Vascepa in order to maintain a monopoly. London-based Hikma eventually launched the first generic version of Vascepa in November 2020, but it said that Amarin's tactics delayed the launch by months, and initially prevented Hikma from supplying enough of its generic to compete meaningfully with the branded version.
- Simply Wall St.
Calculating The Fair Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Does the February share price for Hikma Pharmaceuticals PLC ( LON:HIK ) reflect what it's really worth? Today, we will...
- Simply Wall St.
Hikma Pharmaceuticals PLC (LON:HIK) is largely controlled by institutional shareholders who own 50% of the company
To get a sense of who is truly in control of Hikma Pharmaceuticals PLC ( LON:HIK ), it is important to understand the...
- Simply Wall St.
The one-year shareholder returns and company earnings persist lower as Hikma Pharmaceuticals (LON:HIK) stock falls a further 5.9% in past week
Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...
- Simply Wall St.
Could The Market Be Wrong About Hikma Pharmaceuticals PLC (LON:HIK) Given Its Attractive Financial Prospects?
With its stock down 15% over the past three months, it is easy to disregard Hikma Pharmaceuticals (LON:HIK). However...
PA Media: MoneyFund manager Abrdn drops from FTSE 100 in reshuffle
Howden Joinery and Hikma Pharmaceutical have also dropped from the FTSE 100.
- Simply Wall St.
What Kind Of Shareholders Hold The Majority In Hikma Pharmaceuticals PLC's (LON:HIK) Shares?
If you want to know who really controls Hikma Pharmaceuticals PLC ( LON:HIK ), then you'll have to look at the makeup...
Yahoo Finance UKFTSE 100 shareholders in line for £85bn dividends payout in 2022
London's bluechip index is forecast to yield a 4.2% dividend return this year.
StockopediaAre analysts upbeat on the outlook for Hikma Pharmaceuticals?
While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the coun...
StockopediaIs the Hikma Pharmaceuticals share price too low?
Good shares at cheap prices are what the very best investors look for. At this time of economic turmoil, could Hikma Pharmaceuticals (LON:HIK) be one of them?...
- Simply Wall St.
Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 32% Above Their Intrinsic Value Estimate
How far off is Hikma Pharmaceuticals PLC ( LON:HIK ) from its intrinsic value? Using the most recent financial data...